NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NeuraWorx Medical Technologies

NeuraWorx Medical Technologies

Private
Excelsior, MinnesotaHealthcare & Life Scienceshttps://www.neuraworx.com/

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$225,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NeuraWorx Medical Technologies is a neurotechnology therapeutics company developing the Cerebrovascular Pacing System, a wearable neurostimulator intended to enhance the brain's waste clearance for improved brain health and to treat disorders like traumatic brain injury and Alzheimer's dementia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurotechnologywearable neurostimulatorbioelectronic medicinebrain healthglymphatic systemcerebrovascular pacingneurodegenerative diseasetraumatic brain injuryTBImedical deviceneuromodulationbrain stimulationCNS disordersbiohackingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuraWorx Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

NeuraWorx Medical Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuraWorx Medical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025
SeedAug 27, 2024
AcceleratorJul 12, 2023
DebtMay 31, 2023

NeuraWorx Medical Technologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Feasibility studies for wearable neurostimulation platform are in progress.

  • Dec 18, 2025

    Completed a Seed funding round.

NeuraWorx Medical Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuraWorx Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuraWorx Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersExcelsior, Minnesota
Employee Range6
Year Founded2021
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.